MannKind is trading at $3.86 (5.9% down) in pre-market after its second-quarter 2026 report showed a net loss of $0.06 per share, missing analyst expectations despite a 43% year-over-year revenue increase to $109.4 million.
- Investors are reacting to sharply higher operating expenses tied to recent product approvals and aggressive launch spending.
- Management’s emphasis on prioritizing long-term growth over near-term profitability has pressured the stock following the August 5 earnings call.